The invention generally relates to removal of antibiotic residues from food products. More specifically, the invention relates to removal of antibiotic residues from dairy and poultry products by irradiating ionizing gamma radiation.
Extensive use of antibiotics in veterinary medicine and animal derived food products for disease treatment, prophylaxis, growth promotion and especially for increasing the production of food products such as milk, eggs, meat, etc. has been observed over the years.
Subjection to antibiotics and its discharge has greatly altered the microbial ecosystems of humans, animals and the environment leading to development of antimicrobial resistance towards the antibiotics widely present in the environment. The multiple survival methods of microbes involving antimicrobial resistance includes, but not limited to, decreased uptake, increased efflux of an antibiotic, alteration of binding site topography.
The entry of significant amount of antibiotic residues into the human microbial ecosystem through the animal derived food products induces immunological responses in susceptible individuals and causes disorders in the intestinal flora. Dairy and Poultry consuming countries including developed and developing countries across the globe have identified elevated levels of certain antibiotics (levels exceeding the MRLs (maximum residual limit)). There is need for a process to eliminate antibiotic residues or to control it within the permissible levels of MRLs.
Yet again, economic loss is a huge concern in the milk production industry owing to the antibiotic residues present in milk thereby leading to the discarding and disposal of milk and again effectively reaching the environmental ecosystem. Recycling of milk by feeding the waste milk to calves' builds up antibiotic resistance and microbial contamination such as, but not limited to, E. coli, and bovine viral diarrhea virus.
The erstwhile method and processes involved in removal of antibiotic residues from aqueous media largely involves physical, biological and chemical methods. The physical and biological methods typically include filtration, coagulation, flocculation, and sedimentation have proven to be inefficient in elimination of antibiotic residues in food products. Advanced microfiltration/reverse osmosis technology coupled with UV radiation also cannot eliminate antibiotic residues from wastewater.
Additionally, advanced oxidation processes (AOPs) although considered a highly efficient method in the removal of various organic residues in aqueous media including antibiotics residues, the degradation process occurs by formation of hydroxyl radicals which are highly reactive and non-selective.
Therefore, there is a need for an improved and economically viable method for elimination of antibiotic residues from food products especially dairy and poultry products.
The accompanying figures, where like reference numerals refer to identical or functionally similar elements throughout the separate views and which together with the detailed description below are incorporated in and form part of the specification, serve to further illustrate various embodiments and to explain various principles and advantages all in accordance with the invention.
Before describing in detail embodiments that are in accordance with the present invention, it should be observed that the embodiments reside primarily in combinations of method steps related to removal of antibiotic residues by irradiating ionizing gamma radiation. Accordingly, the method steps have been represented where appropriate by conventional symbols in the drawings, showing only those specific details that are pertinent to understanding the embodiments of the invention so as not to obscure the disclosure with details that will be readily apparent to those of ordinary skill in the art having the benefit of the description herein.
In the present disclosure, the terms “comprises,” “comprising,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. An element proceeded by “comprises . . . a” does not, without more constraints, preclude the existence of additional identical elements in the process, method, article, or apparatus that comprises the element.
Various embodiments of the invention provide a method for removal of antibiotic residue from a food product, wherein the food product is selected from a group of dairy and poultry products. In accordance with the invention, the irradiating of the food product occurs at a dose of ionizing gamma radiation. The dose of ionizing gamma radiation falls within the recommended irradiation doses for food products by the International Atomic Energy Agency (IAEA).
Considering the method of removal of antibiotic residues is from dairy and poultry products, the food products may be veterinary antibiotics. The antibiotic residues found in the dairy and poultry products wherein the antibiotics residues are not limited to, but include P-Lactam antibiotics (penicillin and its derivatives), tetracycline and its derivatives, chloramphenicol and its derivatives, cephalosporin and its derivatives, and azithromycin and its derivatives and its likes thereof.
The antibiotic decomposition is based on an oxidation reaction that takes place between hydroxyl radicals (OH*), produced in situ during water radiolysis by gamma radiation and the antibiotic residues in the food products. Hydroxyl radicals are strong oxidizing species with the ability to break down complex organic molecule like antibiotics into simpler and less toxic radiolytic fragments through chain oxidation reactions.
In accordance with
In accordance with an exemplary embodiment of the invention, the irradiation of the food products occurs for an effective amount of time at step 104. The effective amount of time is defined based on the radioactivity of the source providing the ionizing gamma radiation to the food products. In an embodiment, the method of irradiating ionizing gamma radiation on food products involves a dose rate of 4.177 kGy the dose rate being defined as the quantity of gamma radiation absorbed per unit time. Further, the method of irradiating ionizing gamma radiation on food products involves a transit dose of 5.39 Gy s−1.
Thereafter, at step 106, the irradiated food products are removed from the source after irradiating occurs for the effective amount of time. Lastly, at step 108, the irradiated products may be packaged for human or animal consumption.
The procedures and advantages of the present invention are illustrated in the following representative examples. However, it is understood that the present invention is not limited to these examples and that any modification and correction can be accomplished within the technical scope of the present invention.
In the foregoing examples, irradiation of ionizing gamma radiation was carried out in double distilled water followed by irradiation of ionizing gamma radiation of spiked samples of milk, egg and meat. Examples of suitable antibiotics administered are amoxicillin, doxycycline and ciprofloxacin of analytical grades to represent the commonly used broad-spectrum antimicrobial in veterinary medicine. The antibiotic concentrations in both aqueous solutions (double distilled water) and spiked dairy and poultry products were chosen to fall within the recommended maximum residues limit (MRLs) by the international organizations (such as European Union).
In all the example mentioned in the foregoing, the source of gamma radiation is a Cobalt-60 gamma rays source model Gamma Cell 220 from MDS Nordion, Canada. The source of gamma radiation was calibrated using aqueous ferrous sulfate (Fricke dosimetry) solution.
The three target antibiotics as mentioned above were dissolved in double distilled water to make desired concentrations (in 10 mL volume). Different concentrations of antibiotics (1 |iM to 50 |iM) were irradiated with different doses of 0.5, 1, 2, 5, and 7 kGy of ionizing gamma radiation (0.5 to 7 kGy). This particular range of concentration was selected because the recommended maximum residual limit of the experimented antibiotics in foods fall within this range. UV-Vis absorption spectra of the studied antibiotics in solution were recorded before and after irradiation treatment at different doses. Experiments were conducted in double distilled water to optimize the irradiation dose for further experiments in spiked dairy and poultry products.
With reference to
With reference to
The desired concentration of amoxicillin was spiked in water, milk, eggs, and chicken meat. 20 |iL of spiked water samples before and post irradiation treatment was directly injected in HPLC. Amoxicillin spiked in milk, eggs, and chicken meat was extracted using acetonitrile. 2 mL (milk or eggs) or 2 g (chicken meat) of the spiked samples was mixed with 5 mL acetonitrile and shaken for 10 minutes following which the samples were centrifuged for 5 minutes at a speed of 3000 rpm. 5 mL of the supernatant was evaporated in a rotary-evaporation system and the antibiotic residue was dissolved in 2 mL of double distilled water. 20 |iL of the extracted samples was injected in HPLC.
Direct Uv-Vis measurements cannot be conducted to quantify the antibiotics in samples extracted from dairy or poultry products due to the significant chemical interference.
Removal percentage of amoxicillin in different samples with varied concentrations is reported by comparing the original concentrations with the corresponding post irradiation concentrations (i.e. before and after irradiation).
Further, an additional confirmation of the degradation of amoxicillin was conducted using 1H and 13C NMR studies. Amoxicillin is dissolved in water and diluted at a ratio of 1:1 using D2O. A high concentration of amoxicillin (5 mg/mL) was used for this technique, with water as the NMR solvent.
In addition, the potential of antimicrobial activity of the irradiation decomposition by-product using E-coli growth inhibition experiments, which is known to be susceptible to amoxicillin was conducted. With reference to
Those skilled in the art will realize that the above recognized advantages and other advantages described herein are merely exemplary and are not meant to be a complete rendering of all of the advantages of the various embodiments of the present invention.
In the foregoing specification, specific embodiments of the present invention have been described. However, one of ordinary skill in the art appreciates that various modifications and changes can be made without departing from the scope of the present invention as set forth in the claims below. Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of the present invention. The benefits, advantages, solutions to problems, and any element(s) that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as a critical, required, or essential features or elements of any or all the claims. The present invention is defined solely by the appended claims including any amendments made during the pendency of this application and all equivalents of those claims as issued.